To Ocugen CEO Shankar Musunuri, Ph.D., most gene therapy biotechs today lack vision. | Many gene therapy outfits focus on ...

VCs and universities struggle with different goals and timelines, but tech transfer is helping turn academic science into ...

The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein ...

It was as recently as February that biotech CEOs were talking enthusiastically to Fierce about a positive “shift in the ...

Gilead, AstraZeneca and Vertex have acquired more than just a therapeutic asset in recent deals. BioSpace takes a look at ...

Dow Jones Top Company Headlines at 9 PM ET: Big Pharma Is Turning to China for the Newest Drug Ideas | How ... China's biotechs are faster and have lower costs, and its drug research threatens to soon ...

The stock market rally powers higher with the Nasdaq and Nvidia up for 10 days. Here's what to do now. ASML, Bank of America ...

The developer of a sperm separation device for IVF purposes, Memphasys has disappointed investors for years. Is a rebirth in ...

Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going ...

By Lorna Patrick, Chief Operating Officer, Upperton In the world of outsourced drug development and manufacturing, risk ...

By Jeff Gerrish China could soon overtake America as the world’s biotech powerhouse. Such a development would have dire ...

More than 90% of drugs entering clinical trials fail. Behind that statistic sits a stark economic reality: billions of ...